The remaining category, lacking dominant expression of ASCL1, NEUROD1, and POU2F3, is referred to as inflammatory SCLC (SCLC-I) or triple-negative SCLC (SCLC-TN) [8-10]. This evidence concerns the gene POU2F3 and small cell lung carcinoma.